Current Neuro-Oncology

Volume 25 Number 19
15 October 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 19, 15 October


Gu P, Ding Y, Zheng G, Xu P, Xia X.
Extracranial metastasis of glioblastoma: A case report and literature review.
Int J Surg Case Rep. 2023 Oct 1;111:108895. doi: 10.1016/j.ijscr.2023.108895. PMID: 37812956.
Case report, Review. ˍ

Moritsubo M, Furuta T, Negoto T, Nakamura H, Uchiyama Y, Morioka M, Oshima K, Sugita Y.
A case of a pilocytic astrocytoma with histological features of anaplasia and unprecedent genetic alterations.
Neuropathology. 2023 Oct 1. doi: 10.1111/neup.12946. PMID: 37779355. Case report˰ ˍ

Brady K, Cohen AL.
Differences in Symptom Burden in Primary Brain Tumor Patients Based on Sex, Race, and Ethnicity: a Single-Center Retrospective Study.
J Racial Ethn Health Disparities. 2023 Oct 2. doi: 10.1007/s40615-023-01761-9. PMID: 37783921. Observational study. ˍ

Que T, Huang G, Tan JE, Zhang P, Li Z, Yi G, Zheng H, Yuan X, Xiao X, Liu J, Xu H, Zhang XA, Qi S.
Supramaximal resection based on en-bloc technique reduces tumor burden and prolongs survival in primary supratentorial lobar glioblastoma.
J Neurooncol. 2023 Oct 2. doi: 10.1007/s11060-023-04399-z. PMID: 37783878. Observational study˰ ˍ

Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P.
Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study.
Neurooncol Pract. 2023 Oct 3;11(1):36-45. doi: 10.1093/nop/npad063. PMID: 38222046. Observational study. ˍ

Weller J, Zeyen T, Schäfer N, Schaub C, Potthoff AL, Steinbach JP, Hau P, Seidel C, Goldbrunner R, Tabatabai G, Vatter H, Tzaridis T, Schneider M, Herrlinger U.
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.
J Neurooncol. 2023 Oct 3. doi: 10.1007/s11060-023-04470-9. PMID: 37787906. Interventional study. ˍ


Dadey DYA, Medress ZA, Sharma M, Ugiliweneza B, Wang D, Rodrigues A, Parker J, Burton E, Williams B, Han SS, Boakye M, Skirboll S.
Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
J Neurooncol. 2023 Oct 4. doi: 10.1007/s11060-023-04460-x. PMID: 37792220. Observational study˰ ˍ

Engelhardt M, Grittner U, Krieg S, Picht T.
Preconditioning of the motor network with repetitive navigated transcranial magnetic stimulation (rnTMS) to improve oncological and functional outcome in brain tumor surgery: a study protocol for a randomized, sham-controlled, triple-blind clinical trial.
Trials. 2023 Oct 4;24(1):638. doi: 10.1186/s13063-023-07640-2. PMID: 37794435. Interventional study protocol. ˍ


Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS.
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.
Neuro Oncol. 2023 Oct 4;25(Supplement_4):iv1-iv99. doi: 10.1093/neuonc/noad149. PMID: 37793125. Observational study. ˍ


Sirirungreung A, Lee PC, Hu YH, Liew Z, Ritz B, Heck JE.
Maternal medically diagnosed infection and antibiotic prescription during pregnancy and risk of childhood cancer: A population-based cohort study in Taiwan, 2004 to 2015.
Int J Cancer. 2023 Oct 4. doi: 10.1002/ijc.34744. PMID: 37792464. Observational study˰ ˍ

Fan X, You H, Liu J, Tao X, Wang M, Li K, Yang J, Xie J, Qiao H.
The Utility of Motor Evoked Potential Monitoring for Predicting Postoperative Motor Deficit in Patients With Insular Gliomas.
J Clin Neurophysiol. 2023 Oct 5. doi: 10.1097/WNP.0000000000001026. PMID: 37797240. Observational study˰ ˍ

Loughan AR, Lanoye A, Willis KD, Fox A, Ravyts SG, Zukas A, Kim Y.
Telehealth group Cognitive Behavioral Therapy for Insomnia (CBT-I) in primary brain tumor: Primary outcomes from a single-arm Phase 2 feasibility and proof-of-concept trial.
Neuro Oncol. 2023 Oct 5:noad193. doi: 10.1093/neuonc/noad193. PMID: 37796017. Proof-of-concept trial˰ ˍ

Nair JN, Naidu B, Balasubramanian A, Krishnamurthy G.
Polymorphous low-grade neuroepithelial tumour of young (PLNTY): the new kid on the block.
Childs Nerv Syst. 2023 Oct 5. doi: 10.1007/s00381-023-06162-1. PMID: 37796295. Case report˰ ˍ

Wang Y, Wu X, Luo B, Ren H.
Clinicopathologic features and prognosis analysis of infratentorial diffuse gliomas.
Asian J Surg. 2023 Oct 5:S1015-9584(23)01535-X. doi: 10.1016/j.asjsur.2023.09.119. PMID: 37805332. Letter, Observational study.


Kim J, Kim Y, La J, Park WH, Kim HJ, Park SH, Ku KB, Kang BH, Lim J, Kwon MS, Lee HK.
Supplementation with a high-glucose drink stimulates anti-tumor immune responses to glioblastoma via gut microbiota modulation.
Cell Rep. 2023 Oct 6;42(10):113220∟. doi: 10.1016/j.celrep.2023.113220. PMID: 37804509. Laboratory investigation.

Kinslow C, Siegelin MD, Iwamoto FM, Gallitto M, Neugut AI, Yu JB, Cheng SK, Wang TJC.
MGMT promoter methylation in 1p19q-intact gliomas.
Res Sq [Preprint]. 2023 Oct doi: 10.21203/ PMID: 37886555. Observational study.

Saeed N, Ridzuan M, Alasmawi H, Sobirov I, Yaqub M.
MGMT promoter methylation status prediction using MRI scans? An extensive experimental evaluation of deep learning models.
Med Image Anal. 2023 Oct 6;90:102989. doi: 10.1016/ PMID: 37827111. Observational study.

Ernster AE, Body A, Deleyrolle P, St Clair J, Sampson D, Bacharz K, Yan SC, Melnick K, Allen A, Rahman M, Tran DD, Mitchell DA, Pereira DB, Ghiaseddin AP. Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors.
J Neurooncol. 2023 Oct 7. doi: 10.1007/s11060-023-04469-2. PMID: 37804375. Observational study˰ ˍ

Ciobanu-Caraus O, Czech T, Peyrl A, Haberler C, Kasprian G, Furtner J, Kool M, Sill M, Frischer JM, Cho A, Slavc I, Rössler K, Gojo J, Dorfer C.
The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups.
Cancers (Basel). 2023 Oct 7;15(19):4877. doi: 10.3390/cancers15194877. PMID: 37835571. Observational study.

Kotch C, Si SJ, Desai K, Caminada P, Lo Russo FM, Li Y, Liu GT, Avery RA, Fisher MJ.
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis.
J Neurooncol. 2023 Oct 7. doi: 10.1007/s11060-023-04468-3. PMID: 37803102. Observational study˰ ˍ

Liu Y, Lin HT, Zeng W.
Extensive intraventricular glioblastoma mimicking intracranial lymphoma.
Neurol Sci. 2023 Oct 7. doi: 10.1007/s10072-023-07111-1. PMID: 37804369. Case report˰ ˍ

Tam OCH, Ho RSL, Chan S, Li KKW, Lam TL, Cheung ETY, Cheung OY, Ho WWS, Cheng KKF, Shing MMK, Ku DTL, Chung BHY, Yang W, Chan GCF, Ng HK, Liu APY.
Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong Kong.
Cancers (Basel). 2023 Oct 7;15(19):4880. doi: 10.3390/cancers15194880. PMID: 37835574. Observational study.

Zhou X, Chen B, Tong P, Li L.
A case of primary glioma in the cerebellopontine angle region.
Asian J Surg. 2023 Oct 7:S1015-9584(23)01474-4. doi: 10.1016/j.asjsur.2023.09.059. PMID: 37813794.
Letter, Case report. ˍ

Harness JE, Reis J, Ismail H, Rossing J, Bylsma FW.
A - 170 Neuropsychological Findings after Treatment for Recurrent Left Fronto-Temporal Gemistocytic Astrocytoma.
Arch Clin Neuropsychol. 2023 Oct 8:acad067.187. doi: 10.1093/arclin/acad067.187. PMID: 37807348. Case report˰

Strebler P, Schmitt A.
A - 114 Long Term Cognitive Sequela of Intracranial Radiation Therapy in a Pediatric Cerebellar Medulloblastoma Survivor.
Arch Clin Neuropsychol. 2023 Oct 8:acad067.131. doi: 10.1093/arclin/acad067.131. PMID: 37807253. Case report˰

Sun R, Zisakis A, Metcalfe S, Furtado N.
Intra-cranial hypertension and vision-threatening papilloedema caused by intradural spinal tumours: a case series of three.
Br J Neurosurg. 2023 Oct 8:1-6. doi: 10.1080/02688697.2023.2263087. PMID: 37807636. Case report˰

Aboubakr O, Métais A, Hasty L, Saffroy R, Zanello M, Pallud J, Dhermain F, Varlet P, Tauziède-Espariat A.
Brainstem oligodendroglioma, IDH-mutant, and 1P/19Q-codeleted: A potential diagnostic pitfall.
J Neuropathol Exp Neurol. 2023 Oct 9:nlad070. doi: 10.1093/jnen/nlad070. PMID: 37812786. Letter, Case report.


Dupere JM, Lucido JJ, Breen WG, Mahajan A, Stafford SL, Bradley TB, Blackwell CR, Remmes NB.
Pencil beam scanning proton therapy for pregnant patients with brain and head and neck cancers.
Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07953-1. doi: 10.1016/j.ijrobp.2023.09.040. PMID: 37820769. Observational study.

Inan MA, Ogut B, Toker M, Aricasoy ON, Vural O, Kuzucu P, Poyraz A.
Retrospective Analysis of Paediatric Glial Tumours that Required Modern Molecular Techniques.
Turk Neurosurg. 2023 Oct 10. doi: 10.5137/1019-5149.JTN.44205-23.1. PMID: 37846542. Observational study.

Krauze AV, Zhao Y, Li MC, Shih J, Jiang W, Tasci E, Cooley Zgela T, Sproull M, Mackey M, Shankavaram U, Tofilon P, Camphausen K.
Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation.
Biomolecules. 2023 Oct 10;13(10):1499. doi: 10.3390/biom13101499. PMID: 37892181. Observational study.

Kumagai M, Takata S, Watanabe T, Shioya A, Han J, Shimasaki M, Ueda Y, Hayashi Y, Yamada S.
Glioblastoma/high-grade glioma with a primitive neuronal component including rhabdoid differentiation that was difficult to diagnose: A case report.
Pathol Res Pract. 2023 Oct 10;251:154830. doi: 10.1016/j.prp.2023.154830. PMID: 37890269. Case report˰

Rosenberg JG, Nissen K, Heegaard S, Ragunathan S, Schmiegelow K, Mathiasen R, von Holstein SL.
Nystagmus in children with primary brain tumours in Denmark between 2007 and 2017.
Eye (Lond). 2023 Oct 10. doi: 10.1038/s41433-023-02771-x. PMID: 37816936. Observational study.

Batchelor TT, Won M, Chakravarti A, Hadjipanayis CG, Shi W, Ashby LS, Stieber VW, Robins HI, Gray HJ, Voloschin A, Fiveash JB, Robinson CG, Chamarthy U, Kwok Y, Cescon TP, Sharma AK, Chaudhary R, Polley MY, Mehta MP.
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.
Neurooncol Adv. 2023 Oct 11;5(1):vdad116. doi: 10.1093/noajnl/vdad116. PMID: 38024244. Interventional study.

Eckhardt A, Drexler R, Schoof M, Struve N, Capper D, Jelgersma C, Onken J, Harter PN, Weber KJ, Divé I, Rothkamm K, Hoffer K, Klumpp L, Ganser K, Petersen C, Ricklefs F, Kriegs M, Schüller U.
Mean global DNA methylation serves as independent prognostic marker in IDH wild type glioblastoma.
Neuro Oncol. 2023 Oct 11:noad197. doi: 10.1093/neuonc/noad197. PMID: 37818983. Observational study˰

Krauss P, Kahl KH, Bonk MN, Wolfert C, Sommer B, Stueben G, Shiban E.
Intraoperative radiotherapy after resection of brain metastases located in the posterior fossa. Analysis of postoperative morbidity and mortality in a single center cohort.
J Clin Neurosci. 2023 Oct 11;118:1-6. doi: 10.1016/j.jocn.2023.09.014. PMID: 37832264. Observational study˰

Lo Greco MC, Milazzotto R, Liardo RLE, Foti PV, Palmucci S, Basile A, Pergolizzi S, Spatola C.
The Role of Reirradiation in Childhood Progressive Diffuse Intrinsic Pontine Glioma (DIPG): An Ongoing Challenge beyond Radiobiology.
Brain Sci. 2023 Oct 11;13(10):1449. doi: 10.3390/brainsci13101449. PMID: 37891817. Observational study.

Mehkri Y, Sharaf R, Reddy A, Lucke-Wold B.
Letter: Laser Interstitial Thermal Therapy for First-Line Treatment of Surgically Accessible Recurrent Glioblastoma: Outcomes Compared With a Surgical Cohort.
Neurosurgery. 2023 Oct 11. doi: 10.1227/neu.0000000000002721. PMID: 37819105. Comment.
Refers to: Fadel HA, et al., Laser Interstitial Thermal Therapy for First-Line Treatment of Surgically Accessible Recurrent Glioblastoma: Outcomes Compared With a Surgical Cohort. Neurosurgery. 2022 Aug 19. doi: 10.1227/neu.0000000000002093. PMID: 35986677. Observational study˰ ˍ
Fadel HA, Pawloski JA, Lee IY.
In Reply: Laser Interstitial Thermal Therapy for First-Line Treatment of Surgically Accessible Recurrent Glioblastoma: Outcomes Compared With a Surgical Cohort.
Neurosurgery. 2023 Oct 11
. doi: 10.1227/neu.0000000000002722. PMID: 37819071. Comment. ˍ

Wang W, Zhao Y, Teng L, Yan J, Guo Y, Qiu Y, Ji Y, Yu B, Pei D, Duan W, Wang M, Wang L, Duan J, Sun Q, Wang S, Duan H, Sun C, Guo Y, Luo L, Guo Z, Guan F, Wang Z, Xing A, Liu Z, Zhang H, Cui L, Zhang L, Jiang G, Yan D, Liu X, Zheng H, Liang D, Li W, Li ZC, Zhang Z.
Neuropathologist-level integrated classification of adult-type diffuse gliomas using deep learning from whole-slide pathological images.
Nat Commun. 2023 Oct 11;14(1):6359. doi: 10.1038/s41467-023-41195-9. PMID: 37821431. Observational study.

Das A, Fernandez NR, Levine A, Bianchi V, Stengs LK, Chung J, Negm L, Dimayacyac JR, Chang Y, Nobre L, Ercan AB, Sanchez-Ramirez S, Sudhaman S, Edwards M, Larouche V, Samuel D, Van Damme A, Gass D, Ziegler DS, Bielack SS, Koschmann C, Zelcer S, Yalon-Oren M, Campino GA, Sarosiek T, Nichols KE, Loret De Mola R, Bielamowicz K, Sabel M, Frojd CA, Wood MD, Glover JM, Lee YY, Vanan M, Adamski JK, Perreault S, Chamdine O, Hjort MA, Zapotocky M, Carceller F, Wright E, Fedorakova I, Lossos A, Tanaka R, Osborn M, Blumenthal DT, Aronson M, Bartels U, Huang A, Ramaswamy V, Malkin D, Shlien A, Villani A, Dirks PB, Pugh TJ, Getz G, Maruvka YE, Tsang DS, Ertl-Wagner B, Hawkins C, Bouffet E, Morgenstern DA, Tabori U.
Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: A report from the International RRD Consortium.
Cancer Discov. 2023 Oct 12. doi: 10.1158/2159-8290.CD-23-0559. PMID: 37823831. Observational study˰

Gottardo NG, Gajjar A.
Verschlimmbesserung: Craniospinal Radiotherapy is Essential in WNT Medulloblastoma Patients.
Clin Cancer Res. 2023 Oct 12. doi: 10.1158/1078-0432.CCR-23-2331. PMID: 37823794.
Comment. ˍ
-Refers to: Cohen KJ, et al., A pilot study omitting radiation in the treatment of children with newly diagnosed Wnt-activated medulloblastoma.
Clin Cancer Res. 2023 Jul 27:CCR-23-0348
. doi: 10.1158/1078-0432.CCR-23-0348. PMID: 37498309. Interventional study˰ ˍ

Schmitz-Abecassis B, Dirven L, Jiang J, Keller JA, Croese RJI, van Dorth D, Ghaznawi R, Kant IMJ, Taphoorn MJB, van Osch MJP, Koekkoek JAF, de Bresser J.
MRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival.
Neurooncol Adv. 2023 Oct 12;5(1):vdad133. doi: 10.1093/noajnl/vdad133. PMID: 37908765. Observational study.

Hersh AM, Pennington Z, Lubelski D, Elsamadicy AA, Dea N, Desai A, Gokaslan ZL, Goodwin CR, Hsu W, Jallo GI, Krishnaney A, Laufer I, Lo SL, Macki M, Mehta AI, Ozturk A, Shin JH, Soliman H, Sciubba DM.
Treatment of intramedullary spinal cord tumors: a modified Delphi technique of the North American Spine Society Section of Spine Oncology.
J Neurosurg Spine. 2023 Oct 13:1-10. doi: 10.3171/2023.8.SPINE23190. PMID: 37856379. Observational study˰ ˍ

Picart T, Pallud J, Berthiller J, Dumot C, Berhouma M, Ducray F, Armoiry X, Margier J, Guerre P, Varlet P, Meyronet D, Metellus P, Guyotat J; Members of RESECT study group.
Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study.
J Neurosurg. 2023 Oct 13:1-14. doi: 10.3171/2023.7.JNS231170. PMID: 37856381. Interventional study˰

Sharma P, Medhi PP, Bhattacharyya M, Nath J, Kalita AK.
Prognostic Significance of Neutrophil-Lymphocyte Ratio in Patients of High-Grade Glioma Undergoing Adjuvant Chemoradiation: A Prospective Study.
Asian Pac J Cancer Prev. 2023 Oct 13;24(10):3487-3494. doi: 10.31557/APJCP.2023.24.10.3487. PMID: 37898854. Observational study.

Xiao S, Jiang F, Chen Y, Gong X.
Development and validation of a prediction tool for intraoperative blood transfusion in brain tumor resection surgery: a retrospective analysis.
Sci Rep. 2023 Oct 13;13(1):17428. doi: 10.1038/s41598-023-44549-x. PMID: 37833334. Observational study.

Chiba K, Aihara Y, Oda Y, Masui K, Komori T, Yokoo H, Kawamata T.
Systemic Metastasis of Pediatric Diffuse High-grade Astrocytoma: A Case Report.
NMC Case Rep J. 2023 Oct 14;10:265-271. doi: 10.2176/jns-nmc.2023-0018. PMID: 37953909. Case report. ˍ


van den Elshout R, Herings SDA, Mannil M, Gijtenbeek AMM, Ter Laan M, Smeenk RJ, Meijer FJA, Scheenen TWJ, Henssen DJHA.
Apparent Diffusion Coefficient Metrics to Differentiate between Treatment-Related Abnormalities and Tumor Progression in Post-Treatment Glioblastoma Patients: A Retrospective Study.
Cancers (Basel). 2023 Oct 14;15(20):4990∟. doi: 10.3390/cancers15204990. PMID: 37894355. Observational study.